Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study (REDUCE-TE Pilot)

NCT02275260 is registered in ClinicalTrials.gov with Biotronik SE & Co. KG as lead sponsor.

NCT NCT02275260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02275260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study (REDUCE-TE Pilot)
Lead sponsor
Biotronik SE & Co. KG
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2014
Completion date
February 15, 2018
Enrollment
110 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation